Abstract Objective: Our study aimed to characterize alteration in the immunohistochemical expression of p21 in normal tissue of the salivary gland surrounding pleomorphic adenoma, the tumor cells of pleomorphic adenomas, and carcinoma arising in pleomorphic adenoma. Study design: A selected series of 29 cases of pleomorphic adenomas, and 27 cases of carcinoma ex-pleomorphic adenoma (undifferentiated and adenocarcinoma types) were examined. Results: The results showed that p21 expression was negative in the most components of normal tissue of the salivary gland surrounding pleomorphic adenoma, 24 cases out of 29 of the non tumour duct cells (82.8%), and 28 (96.6%) cases out of 29 of the acinar cells shows negative p21 expression. P21 expression in pleomorphic adenomas shows that 2 cases out of 29 (6.9%) strongly expressed in the duct cells. p21 was strongly expressed in carcinoma cells in 9 (33.3%) cases out of 27. Conclusion: Our data suggest that the strong nuclear staining as an indicator for altered p21, then the alteration of p21 expression would increase from pleomorphic adenoma to carcinoma arising in pleomorphic adenomas (6.9% versus 33.3%).
Introduction
p21 is a cell cycle regulatory protein encoded by the p21 WAF 1 gene which is located on chromosome 6p21.2, (1) (2) . It believed that the inhibitory effects on cell division by p21 are related to cancerous change of normal cells, regulation, cell differentiation and induction of apoptosis involving p53 and Rb (3) . P21 plays an important role in arresting the cell cycle. Loss of function of p21 may favour tumour growth. Pleomorphic salivary adenoma (PSA), the most frequent tumour in salivary glands, can undergo malignant transformation. Carcinoma ex pleomorphic adenoma (CXPA) is more frequent in the 5-6th decades of life (4) (5) . It has been suggested that a carcinoma may develop within a recurrent PSA or when it remains untreated over an extended period of time (6) (7) . Despite the recognized clinical importance of CXPA, little is known about its biology, therefore the diagnosis of CXPA is a challenge for pathologists. The purpose of this study was to determine, with the use of immunohistochemistry, to characterize alteration in the immunohistochemical expression of p21 in normal tissue of the salivary gland surrounding pleomorphic adenoma, the tumor cells of pleomorphic adenomas, and carcinoma arising in pleomorphic adenoma.
Materials and Methods
Case selection A selected series tissue 29 cases of pleomorphic adenomas, and 27 cases of carcinoma ex-pleomorphic adenoma were retrieved from the archive of the oral pathology departments in the North West region of England ( All specimens using hematoxylin and eosin slides were reviewed by two pathologists to confirm the histopathological diagnosis and to reclassify the studied cases. The carcinoma cases classified according to the above mentioned criteria as undifferentiated carcinoma or adenocarcinoma. The local NHS Research Ethics Committee provided a favourable ethical opinion (Ref: 02/104). Immunhistochemistry Paraffin-embedded, 4-µm-thick tissue sections from all 56 specimens were cut. The sections were deparaffinized in xylene and rehydrated through graded alcohols. Sections were processed used streptavidin-biotin-peroxidase method. Briefly, the endogenous peroxidase was blocked by 3% hydrogen peroxidase for 5 min followed by TBS wash. Nonspecific immunoreactivity was blocked by incubation with normal goat serum for 20 minutes. A purified mouse anti-human monoclonal antibody p21 (Pharmingen, San Diego) was diluted to 10 µ/ml in 20 µ/ml tris buffer saline containing 0.1% bovine serum albumin for one hour and fifteen minutes at the room temperature. All sections were washed by TBS for 5 minutes. Sections were incubated with the biotinylated secondary antibody reagent for 30 minutes followed by (TBS) wash for 5 minutes. Slides were incubated with streptavidin and horseradish peroxidase for 30 minutes followed by (TBS) tris buffer saline wash for 5 minutes. Incubate with a prepared chromogenic substrate solution (Diaminobenizidine) for 15 minutes. Sections were counterstained with 0.25% methyl green in distilled water for 5 minutes. Sections were dehydrated and mounted in Depax. Squamous cell carcinoma was used as positive control. Negative control was used only with substitution the primary antibody with TBS (Fig. 1a) . The percentage of P21 positive nuclei was semiquantively assessed by two independent observers and scored as: negative (0) no expression of nuclear protein, (1) weak staining 0-25% of the total cells shows positive staining in the nucleus, (2) (Fig. 1b) . P21 (nuclear staining in stroma) was negative in 29 (100%) cases out of 29. P21 expression in pleomorphic adenoma components p21 nucleus staining was moderate in tumour duct cells in 13 (44.8%) cases out of 29 (Fig. 1c) , 13 (44.8%) cases showed weak staining (Fig. 1d ), 1 (3.4%) case negative staining, and 2 cases (6.9%) strong staining ( (Table 2 ). This means that the incidence of overexpressed p21 in tumour duct cells was higher than in tumour myxochondroid tissue. p21 was strongly expressed in carcinoma cells in 9 (33.3%) cases out of 27 (Fig. 2a) . 5 (18.5%) cases showed moderate staining (. 2b), and 5 (18.5%) cases expressed low staining (Fig. 2c) Discussion p21 belongs to a class of tumour suppressors including p16 and p27, which control progression through the cell cycle by inhibiting the activity of cyclin-cdk complexes.
p21 expression in carcinoma arising in pleomorphic adenoma
No study has been published regarding p21 expression in salivary glands and particularly in carcinoma arising in pleomorphic adenoma.
P21 and normal tissue of salivary glands
In the normal salivary glands (control group) p21 was negative in the non tumour duct cells or the acini. These results are consistent with Rey et al. (9) who studied p21 expression in breast cancer. The normal ducts and acinar cells did not express p21 and the same negative p21 nuclear staining was observed in the five non-neoplastic cases. Clasen et al. (10) analysed the expression of p21 in urothelial carcinoma. Their results revealed that no p21 was expressed in normal mucosa. Jung et al. (11) analysed the expression of p21 in normal and reactive brain in gliomas of various malignancy grades. Immunhistochemical assay showed that the p21 detected in normal and reactive brain tissue with at very low expression.
Expression of p21 in the tumour duct cells and myxochondroid tissue in pleomorphic adenomas
Wilcoxon test showed a significant difference between p21 expression of the nuclear staining in myxochondroid and tumour duct cells, (p value <0.001). p21 expression in pleomorphic adenoma showed that the incidence of aberrant expression of this protein was higher in tumour duct cells than in myxochondroid tissue. Although p21 showed alteration in expression in Many studies used criteria such as negative, low, moderate, and strong staining. This study comprised 29 cases of pleomorphic adenoma and 27 cases of carcinoma ex pleomorphic adenoma, although the sample size is limited but it is bigger compared to other published studies.
We have concluded that the alteration of p21 expression has increased from pleomorphic adenoma to carcinoma arising in pleomorphic adenoma depending on use the p21 strong nuclear staining as a strong indicator for altered p21.
